You are here » Home » Companies » Company Overview » Aurobindo Pharma Ltd

Aurobindo Pharma Ltd.

BSE: 524804 Sector: Health care
NSE: AUROPHARMA ISIN Code: INE406A01037
BSE LIVE 15:42 | 02 Dec 719.40 -24.10
(-3.24%)
OPEN

745.50

HIGH

745.50

LOW

717.15

NSE LIVE 15:57 | 02 Dec 719.55 -23.60
(-3.18%)
OPEN

743.45

HIGH

743.45

LOW

717.00

OPEN 745.50
PREVIOUS CLOSE 743.50
VOLUME 144072
52-Week high 895.00
52-Week low 582.00
P/E 18.39
Mkt Cap.(Rs cr) 42099.29
Buy Price 719.40
Buy Qty 250.00
Sell Price 0.00
Sell Qty 0.00
OPEN 745.50
CLOSE 743.50
VOLUME 144072
52-Week high 895.00
52-Week low 582.00
P/E 18.39
Mkt Cap.(Rs cr) 42099.29
Buy Price 719.40
Buy Qty 250.00
Sell Price 0.00
Sell Qty 0.00

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd

Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December of the year 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as ...> More

Aurobindo Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   42,099
EPS - TTM () [*C] 39.11
P/E Ratio (X) [*C] 18.39
Face Value ()   1
Latest Dividend (%)   125.00
Latest Dividend Date 24 Nov 2016
Dividend Yield (%) 0.35
Book Value / Share () [*C] 144.40
P/B Ratio () [*C] 4.98
[*C] Consolidated     [*S] Standalone

Aurobindo Pharma Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 3775.45 3365.11 12.19
Other Income 8.28 12.19 -32.08
Total Income 3783.73 3377.3 12.03
Total Expenses 2846.24 2586.09 10.06
Operating Profit 937.49 791.21 18.49
Net Profit 605.95 453.91 33.5
Equity Capital 58.52 58.4 -
> More on Aurobindo Pharma Ltd Financials Results

Aurobindo Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Lupin 1488.70 -1.62 67192.47
Dr Reddy's Labs 3179.75 -1.87 54303.77
Cipla 571.40 0.57 45954.85
Aurobindo Pharma 719.40 -3.24 42099.29
Cadila Health. 395.25 -1.09 40461.74
Divi's Lab. 1135.30 -1.19 30136.54
Piramal Enterp. 1638.05 0.14 28264.55
> More on Aurobindo Pharma Ltd Peer Group

Aurobindo Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 53.79
Banks/FIs 0.15
FIIs 26.65
Insurance 0.08
Mutual Funds 7.50
Indian Public 8.64
Custodians 0.00
Other 3.18
> More on Aurobindo Pharma Ltd Share Holding Pattern

Aurobindo Pharma Ltd - Research Reports

Date Broker Action Price Report
15/11 Prabhudas Lilladher Buy 733 PDF IconDetails
15/11 Centrum Broking Buy 772 PDF IconDetails
24/08 Prabhudas Lilladher Buy 788 PDF IconDetails
31/05 Motilal Oswal Buy 786 PDF IconDetails
31/05 Prabhudas Lilladher Buy 786 PDF IconDetails
> More on Aurobindo Pharma Ltd Research Reports

Aurobindo Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -2.77% -2.85% -0.33% -0.34%
1 Month -8.82% -6.47% -4.71% -4.69%
3 Month -7.65% -7.70% -8.07% -8.21%
6 Month -8.88% -8.89% -2.28% -1.63%
1 Year -12.79% -12.33% 0.43% 2.83%
3 Year 372.89% 369.22% 25.52% 30.39%

Aurobindo Pharma Ltd - STOCK STRENGTH

Today's Low/High 717.15
745.50
Week Low/High 712.70
757.00
Month Low/High 681.10
805.00
YEAR Low/High 582.00
895.00
All TIME Low/High 0.56
895.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard